Connect Biopharma Holdings Ltd (CNTB)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$46.0M
Cash & Equivalents
$16.0M
Quarterly Burn Rate
9 mo
Est. Cash Runway
$158M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-07-13 Phase2 Readout
2026-12-01 Phase1 Readout

Active Clinical Trials (10)

NCT #TitlePhaseStatusEnrollment
NCT06733480 Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue OTHER Recruiting 499
NCT06239818 Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents OTHER Recruiting 30
NCT06543277 Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation... OTHER Recruiting 12
NCT06607341 Community Engagement Alliance Against Disparities OTHER Active Not Recruiting 664
NCT06016257 Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study OTHER Recruiting 20
NCT07213986 Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction OTHER Recruiting 12
NCT05437536 The Severe Von Willebrand Disease (sVWD) Patient Registry OTHER Recruiting 400
NCT07315867 Better Social, Emotional Communication, Healthy Relationship and ASD Accommodation Skills: Emotional Intelligence ("EQ")... OTHER Recruiting 20
NCT06940141 Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) PHASE2 Active Not Recruiting 160
NCT04937062 Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy PHASE1 Active Not Recruiting 50

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis